$69.73
-0.90-1.27%
Last update: Oct 27, 4:43 PM
TransMedics Group Inc
TMDXNASDAQ
TransMedics Group (TMDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TransMedics Group (TMDX) last issued guidance on September 10, 2026 for fiscal year 2026. The company guided revenue in the range of $737M - $757M for the period.
Compared to prior guidance, TransMedics Group maintained its revenue forecast from a prior range of $737M - $757M.
TransMedics Group has issued 18 guidance updates between November 3, 2022 and September 10, 2026. During this period, the company raised its outlook 11 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.52 | $0.61 | $0.39 | $0.36 |
| Actual | $0.44 | $0.30 | $0.57 | $0.66 |
| Surprise | -15.4% | -50.8% | +46.2% | +83.3% |
| Revenue | ||||
| Estimate | $184.1M | $174.4M | $155.3M | $144.8M |
| Actual | $189.9M | $173.9M | $160.8M | $143.8M |
| Surprise | +3.20% | -0.26% | +3.50% | -0.69% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.29 | $0.48 | $0.53 | $0.60 |
| Revenue | ||||
| Consensus | $178.8M | $201.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.44 | $0.52 | -15.4 % |
| Q1 | May 5, 2026 | $0.30 | $0.61 | -50.8 % |
| Q4 | Feb 24, 2026 | $0.57 | $0.39 | 46.2 % |
| Q3 | Oct 29, 2025 | $0.66 | $0.36 | 83.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $189.95M | $184.06M | 3.20 % |
| Q1 | May 5, 2026 | $173.93M | $174.38M | -0.26 % |
| Q4 | Feb 24, 2026 | $160.76M | $155.33M | 3.50 % |
| Q3 | Oct 29, 2025 | $143.82M | $144.83M | -0.69 % |
